Skip to Content

'
Jessica P. Hwang, MD, MPH

Present Title & Affiliation

N/A

Education & Training

Degree-Granting Education

1996 The University of Texas Medical School, Houston, TX, MD, Medicine
1996 Emory University, Rollins School of Public Health, Atlanta, GA, MPH, Epidemiology and International Health
1991 The University of Texas, Austin, TX, BA, French Studies

Postgraduate Training

4/2010-9/2010 Clinical Safety and Effectiveness (CS&E) Program, "Patient Scheduling and Appointment Cycle Time in the Ambulatory Treatment Center", The University of Texas MD Anderson Cancer Center, Houston, TX
7/1996-12/2000 Residency, The University of Texas Medical School, Houston, TX, Mark A. Farnie, MD
6/1995-8/1995 William and Flora Hewlett Internship, Carter Presidential Center, Atlanta, GA, William H. Foege, MD
8/1989-7/1990 Sweet Briar College Junior Year in France Program,, University of Paris, The Institute of Pierre and Marie Curie, Paris, France

Board Certifications

1/2002 Internal Medicine

Experience/Service

Academic Appointments

Assistant Professor, Tenure track, Department of General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2005-8/2012
Assistant Professor, Non-tenure track, Department of General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 1/2001-8/2005

Other Appointments/Responsibilities

Member, Community Clinical Oncology Program Research Base Steering Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012

Honors and Awards

2008-2011 National Institutes of Health Loan Repayment Program in Health Disparities, Loan Repayment Program, NIH

Professional Memberships

American Association for the Study of Liver Diseases
Member, 2008-present
American Association for the Study of Liver Diseases - Hepatitis B Special Interest Group
Member, 2011-present
American Association for the Study of Liver Diseases - Hepatobilary Neoplasia Special Interest Group
Member, 2011-present
American Medical Association
Member, 1999-present
American Public Health Association
Reviewer, 2002-present
American Society of Clinical Oncology
Member, 2002-present
Digestive Diseases and Sciences
Reviewer, 6/2012
Harris County Medical Association
Member, 1999-present
Multinational Association of Supportive Care in Cancer
Member, 2008-present
Society of General Internal Medicine
Member, 2002-present
Texas Medical Association
Member, 1999-present

Selected Publications

Peer-Reviewed Original Research Articles
1. Hwang JP, Fisch MJ, Zhang H, Kallen M, Routbort M, Lal L, Vierling JM, Suarez-Almazor M. Low Rates of Hepatitis B Virus Screening at the Onset of Chemotherapy. J Oncol Pract 8(4):e32-39, 7/2012. PMCID: PMC3396827.
2. Kallen MA, Terrell JA, Lewis-Patterson P, Hwang JP. Improving wait time for chemotherapy in an outpatient clinic at a comprehensive cancer center. J Oncol Pract 8(1):1-7, 1/2012. PMCID: PMC3266321.

Abstracts
1. Hwang J, Fisch M, Lok A, Zhang H, Vierling J, Suarez-Almazor M. Effect of national recommendations on hepatitis B virus screening in a large U.S. cancer center. 2012 ASCO's Quality Care Symposium, 11/2012.
2. Escalante C, Meyers C, Reuben J, Wang X, Qiao W, Manzullo E, Alvarez R, Morrow PK, Gonzalez-Angulo A, Wang X.S, Mendoza T, Liu W, Holmes H, Hwang J, Pisters K, Overman M, Cleeland C. Randomized, double blind, placebo-controlled crossover trial of a sustained release methylphenidate in cancer-related fatigue. General Poster Session: Patient and Survivor Care. 2012 ASCO Annual Meeting, 6/2012.
3. Hwang J, Fisch M, Lok A, Zhang H, Vierling J, Suarez-Almazor M. Trends in Hepatitis B Virus Screening in a Large US Cancer Center. DoIM 2012 Research Retreat, 5/2012.
4. Hwang JP, Fisch M, Zhang H, Kallen MA, Vierling J, Suarez-Almazor ME. Hepatitis B Screening and Positivity Prior to Chemotherapy. 2010 Multinational Association of Supportive Care in Cancer (MASCC) International Symposium, 6/2010.

Grant & Contract Support

Title: Widespread vs. selective screening for hepatitis B infection prior to chemotherapy, (additional funding pending full appropriation to NIH/NCI)
Funding Source: NIH/NCI-R21
Role: Principal Investigator
Duration: 1/10/2013 - 12/31/2014

Last updated: 2/25/2013